XML 137 R96.htm IDEA: XBRL DOCUMENT v3.25.4
Fair Value Measurements - Recurring (Changes in Level 3 Measurements) (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]      
Beginning balance $ (58) $ (61)  
Contingent consideration(1) (234) [1],[2] 0 $ 0
Unrealized and realized Gain (Loss) Included in Net Income [3] $ 5 $ (10)  
Fair Value, Net Derivative Asset (Liability), Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Purchased product costs Purchased product costs  
Settlements $ 10 $ 13  
Ending balance (277) (58) $ (61)
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) $ 7 $ (7)  
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Purchased product costs Purchased product costs  
[1] Liability recorded in the third quarter of 2025 related to the BANGL Acquisition earnout provision.
[2] See Note 4 – BANGL, LLC Acquisitions.
[3] Gain/(loss) on derivatives embedded in commodity contracts are recorded in Purchased product costs in the Consolidated Statements of Income.